NASDAQ: ORIC

ORIC Pharmaceuticals, Inc.

Healthcare | Biotechnology

No licensed closing price on file for ORIC. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:13 UTC.

Key facts

Charts

Charts are in the appInteractive charts for ORIC are available in Oxford Ledge.
Open ORIC in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-10-02

2026-10-02DirectorOption exercise3,500$5.6K
2026-10-02DirectorSale-3,200$41.3K
2026-10-02DirectorSale-3,500$45.2K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

Nextech Invest Ltd.7,162,637$77.57M0.0%
BlackRock, Inc.6,823,973$73.90M+14.0%
EcoR1 Capital, LLC6,728,116$72.87M0.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2020-06-10Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersLori KunkelEstimatedSEC 8-K →

Company news

View all →

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ORIC and 5,000+ tickers.

Create a free account — keep ORIC

For your agent

GET /api/data?ticker=ORIC

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt